By Simpson Global Media News Desk
The Federal Government is seeking to expand the role of pharmacists across Nigeria's healthcare system, with the profession expected to contribute more directly to clinical care, public health, digital health, medicine safety and the development of local pharmaceutical manufacturing.
The Coordinating Minister of Health and Social Welfare, Professor Muhammad Ali Pate, represented by the Director overseeing the Office of the Permanent Secretary and Director of Human Resource Management, Tetshoma Dafeta, outlined the government's position in Abuja during a ministerial briefing marking the 2026 World Pharmacists Day.
The 2026 observance, held on September 25, was themed “Empowering Pharmacists for Healthier Futures.”
The government said pharmacists are among the most accessible health professionals in Nigeria and have an important role in medicines supply, preventive care, chronic disease management, patient safety and the rational use of medicines.
The proposed expansion would take pharmacists beyond their traditional image as professionals who dispense prescriptions.
Under the reforms being pursued through the Nigeria Health Sector Renewal Investment Initiative, pharmacists are expected to become more integrated into primary healthcare and specialised clinical services, while also taking on expanded responsibilities in regulated electronic pharmacy platforms and digital health.
The government also linked the initiative to efforts to strengthen Nigeria's domestic pharmaceutical industry and improve access to safe, effective and affordable medicines.
That places pharmacists at the centre of two connected challenges facing the health system: how to make better use of an existing professional workforce and how to strengthen the country's capacity to produce, regulate and safely distribute medicines.
Beyond the dispensing counter
For many Nigerians, the pharmacy is one of the easiest points of access to health advice.
A person may visit a community pharmacy to ask about a prescription, seek advice about a minor illness, check blood pressure or obtain information about the proper use of a medicine.
The government says that accessibility should be used more systematically within the healthcare system.
Pharmacists are trained in medicines, their effects, interactions, dosing, safety and appropriate use.
Their professional role can therefore extend beyond handing medicines to patients after a doctor has written a prescription.
In hospital settings, pharmacists can review medication regimens, identify possible drug interactions, monitor treatment and contribute to multidisciplinary patient care.
In public health, they can participate in health education, preventive programmes, medicine-safety campaigns and other community interventions.
The Federal Ministry of Health and Social Welfare said it wants to strengthen those functions rather than treating pharmacy primarily as a medicines-dispensing service.
The proposed shift would require appropriate professional structures, training and collaboration with doctors, nurses and other healthcare workers.
It would also require clarity about responsibilities.
Expanding pharmacists' participation in healthcare does not mean replacing other health professions.
Instead, the government's stated objective is to make pharmacy expertise part of a more integrated healthcare team.
Why the issue matters
Nigeria has a large and complex healthcare system serving a population spread across urban centres, rural communities and hard-to-reach areas.
Access to doctors and hospitals can be difficult in some communities.
Pharmacies, however, are often physically closer to residents.
This makes pharmacists potentially important points of contact for health information and medicine-related services.
The Federal Ministry of Health has described pharmacists as among the most accessible frontline health professionals.
The practical question is how that accessibility can be converted into structured healthcare support.
For example, a pharmacist who encounters a patient repeatedly seeking medicine for a chronic condition may be able to identify the need for further medical assessment.
A pharmacist involved in medication review can identify potential duplication or interactions.
A community pharmacist can reinforce instructions about how a medicine should be taken and explain possible side effects.
In public-health programmes, pharmacists can support education and awareness.
These functions can become particularly important as Nigeria faces the combined demands of infectious diseases, chronic diseases, medicine shortages, medicine-quality concerns and rising healthcare costs.
Chronic disease management
Noncommunicable diseases require long-term interaction between patients and the health system.
Conditions such as hypertension, diabetes and cardiovascular disease often require patients to take medicines over extended periods.
Medication adherence can become a major issue.
A patient may forget doses, stop treatment because symptoms improve, experience side effects or misunderstand instructions.
Pharmacists can play a role in addressing some of those medicine-related challenges.
The Federal Government specifically identified chronic disease management among areas in which pharmacists already contribute and where their role could be strengthened.
That does not mean pharmacists independently diagnose or manage every medical condition.
Rather, their specialised knowledge of medicines can complement diagnosis and treatment provided by other healthcare professionals.
A more integrated approach can allow pharmacists, doctors and nurses to communicate more effectively about a patient's medication.
The approach is especially relevant where patients use multiple medicines.
As the number of medicines increases, so can the possibility of interactions, duplication and adherence problems.
Medication review can therefore become an important component of patient safety.
Patient safety and medicine errors
Medicine safety is another major part of the government's plans.
A medicine can only deliver its intended benefit when the correct product reaches the correct patient in the correct dose and is used appropriately.
Errors can occur at different stages.
They may involve prescribing, dispensing, administration, storage or patient understanding.
Pharmacists have a professional role in reducing some of these risks.
The Federal Ministry said pharmacists contribute to patient safety and rational medicine use and wants their role strengthened across healthcare delivery.
The National Agency for Food and Drug Administration and Control also highlighted the importance of pharmacists in ensuring that medicines available to Nigerians meet standards for quality, safety and efficacy.
This connects clinical pharmacy with pharmaceutical regulation.
A pharmacist working with a patient is concerned with whether a medicine is appropriate and used safely.
A regulator is concerned with whether products entering the market meet required standards.
Both functions contribute to medicine safety.
The fight against substandard and falsified medicines
The government also wants pharmacists to play a stronger role in efforts against substandard and falsified medicines.
Nigeria has a long-running challenge involving illicit medicines and products that do not meet regulatory requirements.
The issue is particularly serious because patients may not know that a medicine is falsified or unregistered.
A product may look authentic while containing the wrong ingredients, an incorrect dose or no active pharmaceutical ingredient.
The Federal Government said stronger cooperation between pharmacists and regulatory agencies would support efforts to prevent substandard and falsified medicines from reaching patients.
The issue was underscored by a Federal High Court case in Lagos in September.
NAFDAC said the court convicted a trader and two companies after they pleaded guilty to charges involving possession, importation and distribution of unregistered drugs.
The agency said the defendants were found with several medicines it described as fake or unregistered.
The case illustrates the enforcement dimension of medicine safety.
Regulation cannot depend only on inspections of manufacturers.
The supply chain also includes importers, distributors, wholesalers, pharmacies and other sellers.
Pharmacists who operate within regulated systems can therefore form part of the country's defence against unsafe medicines.
Local pharmaceutical manufacturing
The government's pharmacy reforms are also connected to an industrial objective.
Nigeria imports a substantial portion of the medicines and pharmaceutical inputs used by its healthcare system.
Strengthening domestic production is intended to reduce vulnerabilities in supply and improve medicine security.
The Federal Ministry said it is strengthening regulatory frameworks and infrastructure incentives under the National Drug Policy to support increased domestic pharmaceutical manufacturing.
Pharmacists are important to that process because the pharmaceutical industry depends on technical professionals who understand formulation, quality assurance, manufacturing processes, regulatory requirements and medicine safety.
The government therefore sees the profession as part of the industrialisation effort rather than solely as a healthcare-distribution profession.
That approach could create opportunities in manufacturing, research, quality control, regulatory affairs and pharmaceutical innovation.
It also changes the skills required from pharmacists.
A workforce supporting a larger domestic pharmaceutical industry needs opportunities for specialist education, research and continuing professional development.
Digital health and e-pharmacy
Another area highlighted by the government is digital health.
Nigeria's healthcare system is increasingly using digital platforms for communication, records, consultations and medicine-related services.
Electronic pharmacy platforms can make it easier for patients to access medicines and professional advice, particularly where physical access is difficult.
But digital access also creates regulatory challenges.
Patients need confidence that an online pharmacy is legitimate.
They need assurance that medicines are genuine, properly stored and supplied under appropriate conditions.
Prescriptions also need to be handled responsibly.
The government said it wants to promote regulated e-pharmacy and digital-health platforms to ensure that medicine distribution is safe, transparent and traceable.
That emphasis on regulation is important because digital commerce can make it easier for legitimate businesses to reach patients but can also create opportunities for unauthorised sellers.
A regulated digital pharmacy system would need mechanisms for identifying licensed operators, protecting patient information, verifying prescriptions and tracking medicines.
The importance of traceability
Traceability is increasingly important in modern pharmaceutical systems.
If a problem is discovered with a particular medicine batch, regulators need to know where the product was manufactured, where it was distributed and where it was sold.
That information can help authorities respond more quickly to safety problems.
Digital systems can strengthen this process if they are properly designed and implemented.
The Federal Government's reference to safe, transparent and traceable distribution reflects this need.
However, digital systems require reliable infrastructure.
They need electricity, connectivity, secure databases and trained users.
They also require privacy safeguards because health and prescription information can be sensitive.
The expansion of digital pharmacy therefore cannot be separated from the broader digital transformation of Nigeria's health sector.
Pharmacists in primary healthcare
The government also wants pharmacists to contribute more to primary healthcare.
Primary healthcare is often the first level at which people seek assistance.
The Federal Ministry has said pharmacists could play a greater role in areas such as community health screening and routine immunisation awareness, alongside other responsibilities.
The idea is significant because pharmacists are distributed across communities and may encounter patients who do not regularly visit hospitals.
A community pharmacy can therefore become a point for health information and referral.
A patient with an elevated blood-pressure reading, for example, may be advised to seek further medical assessment.
A person who repeatedly requests medicines for a persistent problem may be referred to a healthcare facility.
Such functions can help connect community-level healthcare with formal clinical services.
The effectiveness of the approach would depend on clear protocols, training and referral systems.
Vaccination and public health
Pharmacists can also contribute to public-health campaigns.
The government's World Pharmacists Day discussions identified prevention and public-health delivery among areas where the profession can contribute.
In Lagos, the state Ministry of Health marked the 2026 World Pharmacists Day with an awareness walk and free deworming exercise.
Officials said the programme highlighted the role of pharmacists in medicine safety, disease prevention and community healthcare.
The example illustrates how pharmacy services can extend into community health activities.
However, any expansion into vaccination, screening or other public-health services requires appropriate training, equipment, protocols and regulatory oversight.
It also requires coordination with existing public-health programmes to avoid duplication.
Antimicrobial stewardship
Another area in which pharmacists can contribute is antimicrobial stewardship.
Antibiotics are essential medicines, but inappropriate use can contribute to antimicrobial resistance.
Resistance makes infections harder to treat and can increase healthcare costs and complications.
Pharmacists interact with medicines at several points in the healthcare system.
They can help ensure that antibiotics are used appropriately under applicable prescribing and dispensing rules, educate patients about completing prescribed courses and participate in programmes designed to monitor medicine use.
The 2026 World Pharmacists Day discussions also highlighted the broader contribution of pharmacists to public health and safe medicine use.
For Nigeria, antimicrobial stewardship is particularly important because antibiotics are widely used in communities and healthcare facilities.
A stronger multidisciplinary approach could bring pharmacists more closely into hospital antimicrobial stewardship teams and community education programmes.
Pharmacovigilance
Pharmacovigilance is another responsibility that is becoming increasingly important.
It involves detecting, assessing and preventing adverse effects and other problems associated with medicines.
Nigeria has a national pharmacovigilance system operated through NAFDAC.
The Federal Ministry has highlighted pharmacovigilance as part of the progress and responsibilities of the pharmacy profession.
The challenge is ensuring that adverse reactions are reported consistently.
A patient may experience a side effect but not report it.
A healthcare worker may observe a suspected reaction but fail to document it.
A stronger reporting culture can help regulators identify safety signals.
Pharmacists can contribute by recognising suspected adverse reactions, educating patients and supporting appropriate reporting.
Digital systems could potentially make such reporting faster and easier if they are integrated effectively.
Training becomes more important
Expanding pharmacists' responsibilities inevitably raises questions about education.
A pharmacist who is expected to participate more actively in clinical care needs appropriate clinical training.
A pharmacist involved in digital health needs knowledge of technology, data protection and electronic systems.
A pharmacist working in manufacturing needs technical expertise in pharmaceutical production and quality control.
A pharmacist involved in public health needs training relevant to population-level interventions.
The Federal Government said investment is needed in pharmacy education, clinical residency programmes, continuing professional development, workplace infrastructure, research and innovation.
That is significant because workforce expansion cannot rely on policy statements alone.
Professional responsibilities have to be matched by training and resources.
The workforce question
Nigeria's health system has faced concerns about the distribution and availability of health professionals.
Pharmacy is part of that broader workforce environment.
A policy that expands pharmacists' responsibilities will need to consider how many pharmacists are available, where they are located and which areas of practice have the greatest shortages.
Rural and underserved communities may face different challenges from major urban centres.
An expanded role will therefore need to account for geographic distribution.
It may also require incentives for pharmacists to work in underserved areas.
Training capacity is another consideration.
Universities and other institutions need enough lecturers, facilities and clinical placements to produce qualified graduates.
Specialist areas require additional training.
The Federal Government's emphasis on clinical residency and professional development indicates recognition of that requirement.
Collaboration with doctors and nurses
The expansion of pharmacy services will also depend on cooperation among health professions.
Healthcare is increasingly multidisciplinary.
Patients with chronic illnesses may interact with doctors, nurses, pharmacists, laboratory scientists, nutritionists and other professionals.
Each profession contributes a different area of expertise.
The government has called for stronger collaboration between pharmacists, physicians, nurses and other health professionals.
That collaboration needs practical mechanisms.
Hospitals may need multidisciplinary medication-review meetings.
Primary-healthcare facilities may need referral pathways.
Digital systems may need to allow authorised professionals to share relevant patient information.
Professional boundaries must remain clear while communication improves.
The regulatory role of the Pharmacy Council
The Pharmacy Council of Nigeria also has an important role in the proposed changes.
The council regulates pharmacy practice and helps set standards for the profession.
Its Registrar and Chief Executive, Ibrahim Babashehu Ahmed, called for policy enhancement, regulatory reviews, professional repositioning and stronger capacity building as pharmacists marked World Pharmacists Day.
Those issues are directly connected to the government's reform agenda.
If pharmacists take on expanded responsibilities, regulations may need to reflect new forms of practice.
Digital pharmacy, for example, requires regulatory arrangements that account for online transactions.
Clinical pharmacy requires clear professional standards.
Continuing professional development must keep pace with new medicines and technologies.
The regulatory framework therefore needs to evolve alongside the profession.
Making medicines more affordable
Access to medicines is not only about availability.
It is also about affordability.
A medicine may be physically available in a pharmacy but remain inaccessible to a patient who cannot afford it.
Local manufacturing is one component of the government's strategy to improve medicine security and potentially strengthen supply.
Health insurance is another.
The National Health Insurance Authority said it would continue working with pharmacists on medicine formularies, reimbursement processes and integration of pharmaceutical care into quality-assurance frameworks.
Better integration between pharmacy services and health insurance could help patients obtain prescribed medicines through structured coverage rather than paying the full cost out of pocket.
The extent of that benefit will depend on insurance coverage, reimbursement arrangements, medicine availability and the ability of patients to use the system.
The manufacturing opportunity
The pharmaceutical sector also represents an economic opportunity.
Local production can create jobs in manufacturing, research, logistics, packaging, quality control and distribution.
It can also develop technical expertise.
The Federal Government has therefore linked pharmacy workforce development with industrial development.
The National Coordinator of the Presidential Initiative for Unlocking the Healthcare Value Chain, Dr Abdul Mukhtar, said stronger local manufacturing requires the active participation of pharmacists.
For local manufacturers, a larger pool of skilled pharmaceutical professionals can support expansion.
For universities, it creates demand for specialised training.
For regulators, it increases the importance of strong quality-control systems.
For patients, the intended outcome is a more reliable supply of quality medicines.
What local production cannot solve alone
Domestic pharmaceutical manufacturing is important, but it does not by itself resolve every medicine-access problem.
Manufacturers still need reliable raw materials, electricity, financing, equipment and regulatory approval.
Some pharmaceutical ingredients are imported.
Distribution networks are also necessary.
Medicines have to reach pharmacies and hospitals under appropriate storage conditions.
Cold-chain products require specialised logistics.
The expansion of local production must therefore be accompanied by improvements throughout the pharmaceutical supply chain.
The government's approach, which combines manufacturing with regulatory reform, digital health and workforce development, reflects that broader requirement.
Lessons from Lagos
Lagos provided a practical example of how pharmacy can move into community health during the 2026 World Pharmacists Day programme.
The Lagos State Ministry of Health organised an awareness walk and free deworming exercise at the Alausa-Ikeja Secretariat Complex.
Officials used the occasion to emphasise medicine safety, disease prevention and the role of pharmacists in community healthcare.
Such initiatives demonstrate that the pharmacy profession can operate outside the traditional dispensing environment.
They also illustrate the potential for pharmacies to participate in preventive health.
For such programmes to produce sustained results, however, they need to be linked to regular healthcare services rather than existing only as one-day activities.
Artificial intelligence and pharmacy
The pharmacy profession is also facing technological change.
The Federal Neuro-Psychiatric Hospital in Benin City marked World Pharmacists Day by discussing the preparation of pharmacists for an increasingly artificial-intelligence-driven pharmaceutical practice.
AI could eventually affect several aspects of pharmacy, including medicine information, inventory management, research, data analysis and clinical decision support.
But the technology also creates questions about accuracy, accountability, privacy and professional oversight.
A computer-generated recommendation cannot automatically replace professional judgement.
Healthcare workers need to understand how digital tools work, their limitations and when human review is required.
The inclusion of AI in professional discussions therefore points to another area where continuing education will be important.
Digital pharmacies and patient protection
The growth of online medicine sales makes regulation particularly important.
A patient ordering medicine online may not know whether the seller is properly licensed.
There may also be uncertainty about storage conditions, authenticity and prescription requirements.
The government's emphasis on regulated e-pharmacy is intended to address these concerns.
An effective system would need clear identification of legitimate pharmacies and mechanisms for reporting illegal sellers.
It would also need to protect patient data.
As more health transactions become digital, information about prescriptions and medical conditions could become part of electronic records.
Strong safeguards will be needed to prevent misuse.
Research and innovation
The government has also identified research and innovation as areas requiring investment.
Nigeria's pharmaceutical challenges are not identical to those of other countries.
Local research can address diseases and medicine-use patterns that are particularly relevant to Nigerian communities.
Pharmacists working in universities, hospitals and industry can contribute to that research.
Areas can include medicine formulation, pharmacovigilance, antimicrobial resistance, traditional medicine interactions, supply-chain systems and public-health interventions.
Research can also support local manufacturing.
A stronger relationship between universities, pharmaceutical companies and healthcare institutions could help move research findings into practical products and services.
The economic value of a stronger pharmacy workforce
The pharmacy profession is therefore connected to more than medicine dispensing.
It intersects with healthcare delivery, manufacturing, regulation, research, digital technology and public health.
Strengthening the workforce could generate activity across those areas.
Universities and training institutions would need to expand relevant programmes.
Manufacturers would need skilled staff.
Hospitals would need clinical pharmacists.
Regulators would require technical expertise.
Digital-health companies would need professionals who understand both pharmacy and technology.
Community pharmacies could expand preventive services within applicable regulatory frameworks.
The combined effect could be a more integrated pharmaceutical ecosystem.
But the benefits will depend on implementation.
What happens next
The Federal Ministry of Health has said the expansion of pharmacists' roles will form part of broader health-sector reforms under the Nigeria Health Sector Renewal Investment Initiative.
Several elements will need to move from policy commitments to practical implementation.
These include expanding pharmacy roles in primary and specialised healthcare, strengthening professional training, improving workplace infrastructure, supporting research, expanding local manufacturing and regulating digital pharmacy.
Regulatory agencies including NAFDAC and the Pharmacy Council of Nigeria will also remain important.
Health insurers will have a role in reimbursement and pharmaceutical-care arrangements.
Universities and training institutions will need to prepare pharmacists for changing professional requirements.
Private pharmaceutical companies will be important to manufacturing and supply.
Community pharmacies will be central to the delivery of services close to patients.
The patient remains at the centre
Ultimately, the success of the policy will be measured by what changes for patients.
A patient should be able to obtain a quality medicine from a legitimate source.
The patient should receive appropriate information about how to use it.
The medicine should be available at a price that can be managed through available financing mechanisms.
If an adverse reaction occurs, there should be a functioning reporting system.
If a patient needs further medical attention, there should be a clear referral pathway.
If a medicine is falsified, regulators should be able to trace the supply chain and respond.
And if the medicine is manufactured in Nigeria, it should meet the same requirements for quality, safety and efficacy expected of other approved products.
Those outcomes depend on multiple parts of the health system working together.
A changing profession
The 2026 World Pharmacists Day discussions show that Nigeria's pharmacy profession is being positioned for a broader role.
The Federal Government wants pharmacists to contribute more directly to clinical care, prevention, digital health, medicine safety and industrial development.
Professional regulators are calling for policy and regulatory reforms.
Health institutions are discussing new areas such as artificial intelligence.
State health authorities are using pharmacists in community awareness and preventive-health activities.
The pharmaceutical industry is being linked to the wider health-sector reform agenda.
These developments point to a profession undergoing change.
The traditional role of dispensing medicines remains important.
But it is increasingly being placed alongside clinical, public-health, regulatory, research and industrial responsibilities.
From policy to practice
The central challenge now is implementation.
Expanding a professional role requires more than announcements.
It requires training.
It requires appropriate staffing.
It requires equipment and infrastructure.
It requires regulations that match the new responsibilities.
It requires financing.
And it requires cooperation among the different professions that make up the healthcare system.
The government has already identified several of those requirements, including investment in pharmacy education, clinical residency, continuing professional development, research and workplace infrastructure.
How quickly those measures are implemented will determine how much impact the policy has.
Nigeria's pharmaceutical future
The broader objective is to build a healthcare system in which medicines are safer, more accessible and more reliably supplied.
That objective involves both the professional workforce and the pharmaceutical industry.
Pharmacists occupy a unique position because they connect those two sides.
They understand medicines at the point of manufacture, regulation, distribution and patient use.
That makes them relevant to efforts to improve the entire pharmaceutical chain.
Nigeria's current reforms are therefore not simply about giving pharmacists more responsibilities.
They are also about using existing professional expertise more effectively.
If the reforms are implemented with appropriate training and oversight, pharmacists could become more deeply integrated into primary healthcare, hospitals, public-health programmes and digital systems.
The profession could also contribute more substantially to the growth of domestic pharmaceutical manufacturing.
A broader role for community healthcare
Community pharmacies may become particularly important in this transition.
For many residents, especially in urban areas, a pharmacy may be closer than a hospital.
That accessibility provides an opportunity for health education, preventive services and appropriate referral.
But it also creates a responsibility to ensure that pharmacy services operate within professional and regulatory standards.
The government's emphasis on regulated practice is therefore important.
Greater access should be accompanied by greater accountability.
The road ahead for medicine security
Medicine security has become a major health-system concern.
Nigeria wants a pharmaceutical sector capable of producing more medicines domestically while maintaining quality.
The government has linked this ambition to local manufacturing, regulatory strengthening and professional development.
Pharmacists can contribute at each stage.
They can participate in manufacturing and quality assurance.
They can support safe distribution.
They can advise patients.
They can monitor medicine-related problems.
They can contribute to research.
They can help train future professionals.
The profession's role therefore extends across the pharmaceutical value chain.
Conclusion
Nigeria's 2026 World Pharmacists Day observance has become a platform for a broader discussion about how the country uses pharmaceutical expertise.
The Federal Government says pharmacists should move beyond the traditional perception of medicine dispensers and become more integrated into clinical care, public health, digital health, patient safety and local pharmaceutical manufacturing.
The proposal comes as Nigeria works to improve access to healthcare, strengthen medicine security and develop a more resilient domestic pharmaceutical industry.
Pharmacists already occupy a strategic position in that system.
They work in hospitals, community pharmacies, manufacturing companies, regulatory agencies, universities and public-health programmes.
The challenge is to connect those contributions more effectively.
The government has identified clinical care, preventive services, digital health, e-pharmacy, local manufacturing, medicine safety, research and professional development as areas requiring greater attention.
Professional bodies and regulators have similarly called for stronger policy, regulation and capacity building.
The next stage will be translating those commitments into practical systems.
That means creating appropriate clinical roles, strengthening training and residency programmes, improving professional development, expanding research, supporting local manufacturing and ensuring that digital pharmacy grows under effective regulation.
For patients, the intended result is straightforward: safer medicines, better information, more reliable access and a healthcare system in which different professionals work together around their needs.
For pharmacists, the changes could mean a broader professional mandate and greater participation in decisions affecting patient care.
For Nigeria's pharmaceutical industry, they could contribute to a larger skilled workforce and stronger domestic production capacity.
The 2026 theme, “Empowering Pharmacists for Healthier Futures,” therefore extends beyond a professional celebration.
It reflects a policy question about how Nigeria can use the skills already present in its health system to address medicine safety, chronic disease, public health, digital transformation and pharmaceutical manufacturing.
Whether the proposed changes achieve those objectives will depend on implementation, investment, regulation and collaboration.
But the direction announced by the Federal Government is clear: the pharmacist is being positioned not only at the medicine counter, but increasingly within the wider architecture of Nigerian healthcare.
Comments
Post a Comment